Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 65,686 | 81,106 | 69,155 | 94,208 | 86,825 |
| Cost of Goods | 4,616 | 4,065 | 2,607 | 8,984 | 6,080 |
| Gross Profit | 61,070 | 77,041 | 66,548 | 85,224 | 80,745 |
| Operating Expenses | 208,257 | 91,783 | 103,023 | 1,421 | 100,259 |
| Operating Income | -146,571 | -14,677 | -35,868 | 84,787 | -19,434 |
| Interest Expense | 9,482 | 9,383 | 9,273 | 9,206 | 9,135 |
| Other Income | 4,230 | -77 | 1,997 | -1,474 | -3,728 |
| Pre-tax Income | -151,823 | -24,137 | -43,144 | 74,107 | -32,297 |
| Net Income Continuous | -151,823 | -24,137 | -43,144 | 74,107 | -32,297 |
| Net Income Discontinuous | -22,528 | -25,243 | N/A | N/A | N/A |
| Net Income | $-174,351 | $-49,380 | $-43,144 | $12,085 | $-32,297 |
| EPS Basic Total Ops | -1.14 | -0.32 | -0.29 | 0.10 | -0.22 |
| EPS Basic Continuous Ops | -0.99 | -0.16 | -0.29 | 0.50 | -0.22 |
| EPS Basic Discontinuous Ops | -0.15 | -0.17 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.14 | -0.32 | -0.29 | 0.10 | -0.22 |
| EPS Diluted Continuous Ops | -0.99 | -0.16 | -0.29 | 0.50 | -0.22 |
| EPS Diluted Discontinuous Ops | -0.15 | -0.17 | N/A | N/A | N/A |
| EBITDA(a) | $-144,436 | $-10,802 | $-30,602 | $88,103 | $-15,773 |